These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22910292)

  • 1. Targeting Axl with an high-affinity inhibitory aptamer.
    Cerchia L; Esposito CL; Camorani S; Rienzo A; Stasio L; Insabato L; Affuso A; de Franciscis V
    Mol Ther; 2012 Dec; 20(12):2291-303. PubMed ID: 22910292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A neutralizing RNA aptamer against EGFR causes selective apoptotic cell death.
    Esposito CL; Passaro D; Longobardo I; Condorelli G; Marotta P; Affuso A; de Franciscis V; Cerchia L
    PLoS One; 2011; 6(9):e24071. PubMed ID: 21915281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective delivery of therapeutic single strand antimiRs by aptamer-based conjugates.
    Catuogno S; Rienzo A; Di Vito A; Esposito CL; de Franciscis V
    J Control Release; 2015 Jul; 210():147-59. PubMed ID: 25998051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axl-148b chimeric aptamers inhibit breast cancer and melanoma progression.
    Quirico L; Orso F; Esposito CL; Bertone S; Coppo R; Conti L; Catuogno S; Cavallo F; de Franciscis V; Taverna D
    Int J Biol Sci; 2020; 16(7):1238-1251. PubMed ID: 32174798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aptamer-miR-34c Conjugate Affects Cell Proliferation of Non-Small-Cell Lung Cancer Cells.
    Russo V; Paciocco A; Affinito A; Roscigno G; Fiore D; Palma F; Galasso M; Volinia S; Fiorelli A; Esposito CL; Nuzzo S; Inghirami G; de Franciscis V; Condorelli G
    Mol Ther Nucleic Acids; 2018 Dec; 13():334-346. PubMed ID: 30340138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Targeting of AXL Receptor Tyrosine Kinase Inhibits Tumor Growth and Intraperitoneal Metastasis in Ovarian Cancer Models.
    Kanlikilicer P; Ozpolat B; Aslan B; Bayraktar R; Gurbuz N; Rodriguez-Aguayo C; Bayraktar E; Denizli M; Gonzalez-Villasana V; Ivan C; Lokesh GLR; Amero P; Catuogno S; Haemmerle M; Wu SY; Mitra R; Gorenstein DG; Volk DE; de Franciscis V; Sood AK; Lopez-Berestein G
    Mol Ther Nucleic Acids; 2017 Dec; 9():251-262. PubMed ID: 29246304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aptamer targeting EGFRvIII mutant hampers its constitutive autophosphorylation and affects migration, invasion and proliferation of glioblastoma cells.
    Camorani S; Crescenzi E; Colecchia D; Carpentieri A; Amoresano A; Fedele M; Chiariello M; Cerchia L
    Oncotarget; 2015 Nov; 6(35):37570-87. PubMed ID: 26461476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligonucleotide aptamers against tyrosine kinase receptors: Prospect for anticancer applications.
    Camorani S; Crescenzi E; Fedele M; Cerchia L
    Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):263-277. PubMed ID: 29574128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligonucleotide aptamers for glioma targeting: an update.
    Camorani S; Cerchia L
    Cent Nerv Syst Agents Med Chem; 2015; 15(2):126-37. PubMed ID: 25924917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved Cancer Targeting by Multimerizing Aptamers on Nanoscaffolds.
    Omer M; Andersen VL; Nielsen JS; Wengel J; Kjems J
    Mol Ther Nucleic Acids; 2020 Dec; 22():994-1003. PubMed ID: 33251048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developing and Characterization of Chemically Modified RNA Aptamers for Targeting Wild Type and Mutated c-KIT Receptor Tyrosine Kinases.
    Shraim AS; Hunaiti A; Awidi A; Alshaer W; Ababneh NA; Abu-Irmaileh B; Odeh F; Ismail S
    J Med Chem; 2020 Mar; 63(5):2209-2228. PubMed ID: 31369705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axl-Targeted Delivery of the Oncosuppressor miR-137 in Non-small-Cell Lung Cancer.
    Nuzzo S; Catuogno S; Capuozzo M; Fiorelli A; Swiderski P; Boccella S; de Nigris F; Esposito CL
    Mol Ther Nucleic Acids; 2019 Sep; 17():256-263. PubMed ID: 31276956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MerTK inhibition is a novel therapeutic approach for glioblastoma multiforme.
    Knubel KH; Pernu BM; Sufit A; Nelson S; Pierce AM; Keating AK
    Oncotarget; 2014 Mar; 5(5):1338-51. PubMed ID: 24658326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AXL-Receptor Targeted 14FN3 Based Single Domain Proteins (Pronectins™) from 3 Synthetic Human Libraries as Components for Exploring Novel Bispecific Constructs against Solid Tumors.
    Hokanson CA; Zacco E; Cappuccilli G; Odineca T; Crea R
    Biomedicines; 2022 Dec; 10(12):. PubMed ID: 36551940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editorial: Development of small molecule inhibitors and antibodies targeting AXL for tumor therapy and infectious disease control.
    Pyo KH; Rahman SMM; Boraschi D
    Front Oncol; 2022; 12():1121120. PubMed ID: 36703780
    [No Abstract]   [Full Text] [Related]  

  • 16. Multifunctional aptamer-miRNA conjugates for targeted cancer therapy.
    Esposito CL; Cerchia L; Catuogno S; De Vita G; Dassie JP; Santamaria G; Swiderski P; Condorelli G; Giangrande PH; de Franciscis V
    Mol Ther; 2014 Jun; 22(6):1151-1163. PubMed ID: 24441398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of receptor signaling and of glioblastoma-derived tumor growth by a novel PDGFRβ aptamer.
    Camorani S; Esposito CL; Rienzo A; Catuogno S; Iaboni M; Condorelli G; de Franciscis V; Cerchia L
    Mol Ther; 2014 Apr; 22(4):828-41. PubMed ID: 24566984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AXL kinase as a novel target for cancer therapy.
    Wu X; Liu X; Koul S; Lee CY; Zhang Z; Halmos B
    Oncotarget; 2014 Oct; 5(20):9546-63. PubMed ID: 25337673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical validation of AXL receptor as a target for antibody-based pancreatic cancer immunotherapy.
    Leconet W; Larbouret C; Chardès T; Thomas G; Neiveyans M; Busson M; Jarlier M; Radosevic-Robin N; Pugnière M; Bernex F; Penault-Llorca F; Pasquet JM; Pèlegrin A; Robert B
    Oncogene; 2014 Nov; 33(47):5405-14. PubMed ID: 24240689
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.